Wells Fargo & Company »

Acasti Pharma shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Acasti Pharma (GRCE) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Acasti Pharma

Tip: Access up to 7 years of quarterly data

All positions including Acasti Pharma held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acasti Pharma by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.3k 1.8k 4.63

More positions owned by Wells Fargo & Company

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
NVIDIA Corporation Put Option (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon Put Option (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Core Msci Emkt (IEMG)

View all positions for Wells Fargo & Company

Top funds holding Acasti Pharma

HPM Partners
Nantahala Capital Management
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Jane Street
Renaissance Technologies
Citadel Advisors
Connective Capital Management
Birchview Capital
Diametric Capital
XTX Topco
UBS Group
Kestra Private Wealth Services
Oppenheimer & Co

View all funds holding Acasti Pharma